Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139880313> ?p ?o ?g. }
- W2139880313 endingPage "793" @default.
- W2139880313 startingPage "785" @default.
- W2139880313 abstract "Do women with the polycystic ovary syndrome (PCOS) differ from those with the metabolic syndrome (MetS) in markers of insulin resistance (IR) and circulating androgens?Women with MetS have more pronounced IR than those with PCOS whereas only the latter have elevated circulating androgens.PCOS and MetS share many similarities, including abdominal obesity and IR, and PCOS is regarded as the ovarian manifestation of MetS. However, there are limited data on the differences between markers of IR and circulating androgens between women with these two syndromes.A prospective study in 1223 Caucasian women with PCOS and 277 women without PCOS, matched for BMI, was performed between May 2004 and December 2011. The presence/absence of MetS in PCOS+ and PCOS- women was recorded and comparisons among the resulting four groups were performed.This study was performed in a university department of obstetrics and gynecology. The following markers of IR were determined: serum glucose and insulin levels, glucose/insulin ratio, area under the oral glucose tolerance test, homeostasis model assessment of IR index and quantitative insulin sensitivity check index.PCOS+MetS+ women (n = 361) were more insulin-resistant than PCOS+MetS- women (n = 862) (P < 0.001 for the comparisons in all markers of IR). Similarly, PCOS-MetS+ women (n = 66) were more insulin-resistant than PCOS-MetS- women (n = 211) (P < 0.001 for the comparisons in all markers of IR). In contrast, PCOS+MetS+ showed only borderline significant differences in some markers of IR compared with PCOS-MetS+ women (P < 0.05). Similarly, PCOS+MetS- women showed only borderline significant differences in some markers of IR compared with PCOS-MetS- women (P = 0.037). Moreover, PCOS-MetS+ women were more insulin-resistant than PCOS + MetS- women (P < 0.001 for the comparisons in all markers of IR). Regarding circulating androgens, PCOS+MetS+ women had higher levels of circulating androgens than PCOS-MetS+ women (P < 0.001 for the comparisons in all circulating androgens). Similarly, PCOS+MetS- women had higher levels of circulating androgens than PCOS-MetS- women (P < 0.001 for the comparisons in all circulating androgens). In contrast, circulating androgens did not differ between PCOS+MetS+ women and PCOS+MetS- women. Similarly, circulating androgens did not differ between PCOS-MetS+ women and PCOS-MetS- women.Only Caucasian women were included in the study. IR was not assessed with the euglycemic hyperinsulinemic clamp.Even though MetS and PCOS have many similarities, they are distinct disorders. PCOS does not appear to simply represent the ovarian manifestation of MetS. Further studies are required to assess the contribution of hyperandrogenism to the pathogenesis of IR in PCOS.No external funding was either sought or obtained for this study." @default.
- W2139880313 created "2016-06-24" @default.
- W2139880313 creator A5004001879 @default.
- W2139880313 creator A5010226259 @default.
- W2139880313 creator A5019297984 @default.
- W2139880313 creator A5032180952 @default.
- W2139880313 creator A5048220040 @default.
- W2139880313 creator A5076157401 @default.
- W2139880313 date "2013-01-12" @default.
- W2139880313 modified "2023-09-24" @default.
- W2139880313 title "Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome" @default.
- W2139880313 cites W1898081651 @default.
- W2139880313 cites W1970586482 @default.
- W2139880313 cites W1975853136 @default.
- W2139880313 cites W1984067141 @default.
- W2139880313 cites W1991026143 @default.
- W2139880313 cites W2033124742 @default.
- W2139880313 cites W2038225352 @default.
- W2139880313 cites W2042332011 @default.
- W2139880313 cites W2055972547 @default.
- W2139880313 cites W2057023689 @default.
- W2139880313 cites W2063485400 @default.
- W2139880313 cites W2095810284 @default.
- W2139880313 cites W2096740997 @default.
- W2139880313 cites W2101007245 @default.
- W2139880313 cites W2103700278 @default.
- W2139880313 cites W2103714496 @default.
- W2139880313 cites W2104034204 @default.
- W2139880313 cites W2106378688 @default.
- W2139880313 cites W2106998956 @default.
- W2139880313 cites W2107732097 @default.
- W2139880313 cites W2110925381 @default.
- W2139880313 cites W2116404316 @default.
- W2139880313 cites W2116785242 @default.
- W2139880313 cites W2119269482 @default.
- W2139880313 cites W2121081996 @default.
- W2139880313 cites W2122707428 @default.
- W2139880313 cites W2129448542 @default.
- W2139880313 cites W2143104968 @default.
- W2139880313 cites W2144997397 @default.
- W2139880313 cites W2148824946 @default.
- W2139880313 cites W2152097518 @default.
- W2139880313 cites W2152462879 @default.
- W2139880313 cites W2153078139 @default.
- W2139880313 cites W2153408202 @default.
- W2139880313 cites W2160234571 @default.
- W2139880313 cites W2161221983 @default.
- W2139880313 cites W4211231448 @default.
- W2139880313 cites W4230284962 @default.
- W2139880313 cites W4230870013 @default.
- W2139880313 cites W4239520013 @default.
- W2139880313 cites W4256605237 @default.
- W2139880313 doi "https://doi.org/10.1093/humrep/des456" @default.
- W2139880313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23315058" @default.
- W2139880313 hasPublicationYear "2013" @default.
- W2139880313 type Work @default.
- W2139880313 sameAs 2139880313 @default.
- W2139880313 citedByCount "18" @default.
- W2139880313 countsByYear W21398803132013 @default.
- W2139880313 countsByYear W21398803132014 @default.
- W2139880313 countsByYear W21398803132015 @default.
- W2139880313 countsByYear W21398803132016 @default.
- W2139880313 countsByYear W21398803132018 @default.
- W2139880313 countsByYear W21398803132019 @default.
- W2139880313 countsByYear W21398803132021 @default.
- W2139880313 countsByYear W21398803132023 @default.
- W2139880313 crossrefType "journal-article" @default.
- W2139880313 hasAuthorship W2139880313A5004001879 @default.
- W2139880313 hasAuthorship W2139880313A5010226259 @default.
- W2139880313 hasAuthorship W2139880313A5019297984 @default.
- W2139880313 hasAuthorship W2139880313A5032180952 @default.
- W2139880313 hasAuthorship W2139880313A5048220040 @default.
- W2139880313 hasAuthorship W2139880313A5076157401 @default.
- W2139880313 hasConcept C126322002 @default.
- W2139880313 hasConcept C134018914 @default.
- W2139880313 hasConcept C2776405666 @default.
- W2139880313 hasConcept C2777391703 @default.
- W2139880313 hasConcept C2777693730 @default.
- W2139880313 hasConcept C2778535154 @default.
- W2139880313 hasConcept C2778901321 @default.
- W2139880313 hasConcept C2779306644 @default.
- W2139880313 hasConcept C2780578515 @default.
- W2139880313 hasConcept C3017594256 @default.
- W2139880313 hasConcept C3018442814 @default.
- W2139880313 hasConcept C511355011 @default.
- W2139880313 hasConcept C71924100 @default.
- W2139880313 hasConceptScore W2139880313C126322002 @default.
- W2139880313 hasConceptScore W2139880313C134018914 @default.
- W2139880313 hasConceptScore W2139880313C2776405666 @default.
- W2139880313 hasConceptScore W2139880313C2777391703 @default.
- W2139880313 hasConceptScore W2139880313C2777693730 @default.
- W2139880313 hasConceptScore W2139880313C2778535154 @default.
- W2139880313 hasConceptScore W2139880313C2778901321 @default.
- W2139880313 hasConceptScore W2139880313C2779306644 @default.
- W2139880313 hasConceptScore W2139880313C2780578515 @default.
- W2139880313 hasConceptScore W2139880313C3017594256 @default.
- W2139880313 hasConceptScore W2139880313C3018442814 @default.
- W2139880313 hasConceptScore W2139880313C511355011 @default.